CHARACTERZING THE USE OF PALLIATIVE DRUGS ON 57 CANCER PATIENTS, AT DATEH DISTRICT HEALTH CENTER, LAMDONG PROVINCE
Từ khóa:
Palliative treatment, cancerTóm tắt
Purpose: We aimed to characterize the use of palliative drugs in cancer patients, treated at the Dateh District Medical Center, Lamdong province. In order to further clarify the effect of drugs in palliative treatment for cancer patients.
Methods: Retrospective, cross-sectional descriptive study.
Results: The proportion of patients using palliative drugs from the time of admission to the end of the study: 3rd class analgesics increased from 42.11% to 71.93%; 1st class analgesics decreased from 28.07% to 12.28%, and 2nd from 36.84% to 15.79%. The majority of patients used 2 drugs (54.39%), followed by 1 drug (24.56%) and 3 drugs (21.05%).
The dosage of palliative drugs used is within the recommended limits. Drug route: at the time of admission, the majority of patients used drugs orally (50.88%), followed by intramuscular injection (31.58%), intravenous infusion (15.79%) and penetrates through the skin (1.75%). At the end of the study, the majority of patients received the drug intramuscularly (49.12%), followed by intravenous infusion (24.56%) and oral (22.81%).
Tài liệu tham khảo
Hensel M, Schwenk W, Bloch A, et al (2006), “The role of anesthesiology in fast track concepts in colonic surgery”, Anaesthesist, 55 (1): 80-92.
Deborah Dowell, Tamara M Haegerich, Roger Chou (2016), “CDC guideline for prescribing opioids for chronic pain - United States, 2016”, Jama, 315 (15): 1624-1645.
Laxmaiah Manchikanti, Adam M Kaye, Nebojsa Nick Knezevic, et al (2017), “Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines”, Pain physician, 20 (2): S3-S92.
Anniek D Masman, Monique van Dijk, Dick Tibboel, et al (2015), “Medication use during end-of-life care in a palliative care centre”, International journal of clinical pharmacy, 37 (5): 767-775.
N.J.H Raijmakers, Lia van Zuylen, C.J Furst, et al (2013), “Variation in medication use in cancer patients at the end of life: a cross-sectional analysis”, Supportive Care in Cancer, 21 (4): 1003-1011.
Eric Prommer (2020), “Midazolam: an essential palliative care drug”, Palliative care and social practice, 14: 2632352419895527.
Michael R Lux, Bridget McCrate Protus, Jason Kimbrel, et al (2017), “A survey of hospice and palliative care physicians regarding palliative sedation practices”, American Journal of Hospice and Palliative Medicine®, 34 (3): 217-222.
Paul A Kvale, Michael Simoff, Udaya B.S Prakash (2003), “Palliative care”, Chest, 123 (1): 284S-311S.
Liisa Koivu, Tuukka Pölönen, Teija Stormi, et al (2014), “End-of-life pain medication among cancer patients in hospice settings”, Anticancer research, 34 (11): 6581-6584.
Jane Vella-Brincat, A.D Macleod (2004), “Haloperidol in palliative care”, Palliative medicine, 18(3): 195-201.
